A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis

被引：0
|
作者：
Timothy J. Vreeland
Guy T. Clifton
Diane F. Hale
Robert C. Chick
Annelies T. Hickerson
Jessica L. Cindass
Alexandra M. Adams
Phillip M. Kemp Bohan
Robert H. I. Andtbacka
Adam C. Berger
James W. Jakub
Jeffrey J. Sussman
Alicia M. Terando
Thomas Wagner
George E. Peoples
Mark B. Faries
机构：
[1] Uniformed Services University of Health Sciences,Department of Surgery
[2] Brooke Army Medical Center,Department of Surgical Oncology
[3] University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
[4] Brooke Army Medical Center,Department of Surgery
[5] Huntsman Cancer Institute,undefined
[6] Rutgers Cancer Institute of New Jersey,undefined
[7] Mayo Clinic,undefined
[8] University of Cincinnati Cancer Institute,undefined
[9] USC Norris Comprehensive Cancer Center,undefined
[10] Orbis Health Solutions,undefined
[11] Cancer Vaccine Development Program,undefined
[12] The Angeles Clinic,undefined
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6126 / 6137
页数：11
相关论文
共 50 条
  • [21] Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
    John M. Kirkwood
    Michele Del Vecchio
    Jeffrey Weber
    Christoph Hoeller
    Jean-Jacques Grob
    Peter Mohr
    Carmen Loquai
    Caroline Dutriaux
    Vanna Chiarion-Sileni
    Jacek Mackiewicz
    Piotr Rutkowski
    Petr Arenberger
    Gaelle Quereux
    Tarek M. Meniawy
    Paolo A. Ascierto
    Alexander M. Menzies
    Piyush Durani
    Maurice Lobo
    Federico Campigotto
    Brian Gastman
    Georgina V. Long
    Nature Medicine, 2023, 29 : 2835 - 2843
  • [22] A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma
    Lo, Chung Mau
    Liu, Chi Leung
    Chan, See Ching
    Lam, Chi Ming
    Poon, Ronnie T. P.
    Ng, Irene O. L.
    Fan, Sheung Tat
    Wong, John
    ANNALS OF SURGERY, 2007, 245 (06) : 831 - 842
  • [23] Initial analysis of open-label administration of autologous tumor lysate (TL) plus dendritic cells (DC) vaccine (TLPLDC) in melanoma patients who recurred during a phase IIb adjuvant vaccine trial
    Brown, Tommy A.
    Myers, John W.
    Vreeland, Tim J.
    Hale, Diane F.
    Peace, Kaitlin M.
    Jackson, Doreen O.
    Greene, Julia M.
    Greene, Julia M.
    Berry, John S.
    Herbert, Garth
    Yu, Xianzhong
    Wagner, Thomas
    Clifton, Guy Travis
    Peoples, George
    CANCER RESEARCH, 2018, 78 (13)
  • [24] Phase I/II trial of a PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma.
    Hawkins, R. E.
    Dangoor, A.
    Keilholz, U.
    Schadendorf, D.
    Harris, A.
    Ottensmeier, C.
    Smyth, J.
    Hoffmnan, K.
    Anderson, R.
    Pearce, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 460S - 460S
  • [25] FEASIBILITY REPORT OF A RANDOMIZED MULTICENTER CONTROLLED PHASE III TRIAL OF ADJUVANT UFT/LV THERAPY AFTER RESECTION FOR LIVER METASTASIS FROM COLORECTAL CARCINOMA
    Yamamoto, J.
    Hatsuse, K.
    Kokudo, N.
    Oba, M.
    Takayama, T.
    Miyagawa, S.
    Bandai, Y.
    Hasegawa, K.
    Saiura, A.
    Makuuchi, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 211 - 212
  • [26] Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: The final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial
    Wallack, MK
    Sivanandham, M
    Balch, CM
    Urist, MM
    Bland, KI
    Murray, D
    Robinson, WA
    Flaherty, L
    Richards, JM
    Bartolucci, AA
    Rosen, L
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (01) : 69 - 77
  • [27] Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis
    Carpenter, Elizabeth Lee
    Van Decar, Spencer
    Adams, Alexandra M.
    O'Shea, Anne E.
    McCarthy, Patrick
    Chick, Robert Connor
    Clifton, Guy Travis
    Vreeland, Timothy
    Valdera, Franklin A.
    Tiwari, Ankur
    Hale, Diane
    Kemp Bohan, Phillip
    Hickerson, Annelies
    Smolinsky, Todd
    Thomas, Katryna
    Cindass, Jessica
    Hyngstrom, John
    Berger, Adam C.
    Jakub, James
    Sussman, Jeffrey J.
    Shaheen, Montaser F.
    Yu, Xianzhong
    Wagner, Thomas E.
    Faries, Mark
    Peoples, George E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [28] Dosage Matters A Phase IIb Randomized Controlled Trial of Motor Therapy in the Chronic Phase After Stroke
    Winstein, Carolee
    Kim, Bokkyu
    Kim, Sujin
    Martinez, Clarisa
    Schweighofer, Nicolas
    STROKE, 2019, 50 (07) : 1831 - 1837
  • [29] Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma
    Markovic, S
    Suman, VJ
    Dalton, RJ
    Woods, JE
    Fitzgibbons, RJ
    Wold, LE
    Buckner, JC
    Kugler, JW
    Mailliard, JA
    Rowland, KM
    Krook, JE
    Brown, DW
    Tirona, MT
    Creagan, ET
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (06): : 552 - 556
  • [30] RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection
    Basse, C.
    Botticella, A.
    Molina, T. J.
    Falcoz, P. E.
    Oulkhouir, Y.
    Kerjouan, M.
    Pichon, E.
    Westeel, V
    Thiberville, L.
    Quantin, X.
    Clement-Duchene, C.
    Khalifa, J.
    Le Tinier, F.
    Ginoux, M.
    Thillays, F.
    Mordant, P.
    Besse, B.
    Thomas, P. A.
    Le Pechoux, C.
    Girard, Nicolas
    CLINICAL LUNG CANCER, 2021, 22 (05) : 469 - 472
12345